1. Council for International Organizations of Medical Sciences. Management of Safety Information from Clinical Trials. Geneva, Switzerland: Council for International Organizations of Medical Sciences; 2005.
2. Crowe BJ, Xia HA, Berlin JA, et al. Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team. Clinical Trials. 2009;6(5):430–440.
3. Talbot J, Aronson JK. Stephens’ Detection and Evaluation of Adverse Drug Reactions Principles and Practices. 6th ed. New York, NY: John Wiley & Sons Ltd; 2012.
4. Jiang Q, Xia HA. Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting. New York, NY: Taylor & Francis; 2015.
5. Food and Drug Administration. Guidance for Industry and Investigators, Safety Reporting Requirements for INDs and BA/BE Studies. Silver Spring, MD: Food and Drug Administration; 2012.